Company leaders on Twitter are still a rare breed. According to a 2014 survey*, 68% of Fortune 500 company heads have no personal presence on any social media platform. So what motivates the minority who do tweet from the top? How do they find the time? And does it really make a difference to their…
We were really thrilled to have such an enthusiastic response to the webinar we ran last week with the PharmaMKT LinkedIn group, “7 Key LinkedIn Changes Pharma Marketers Can’t Afford to Miss”. During the session we packed in a lot, from new ways to sort and message your contacts and to raise your visibility on…
If you’re a supplier or consultant to the Pharma industry who wants to build their business online, producing content (perhaps writing a blog, LinkedIn updates or emails to your contacts) is crucial. But what do you write about? In this short video – less than 3 minutes long – you’ll discover the golden rule….. Here’s…
For all the talk of Pharma being behind on social media, many of the major drugs companies have a good handle on Twitter. If you follow @boehringer, @sanofi, @AstraZeneca, @pfizer and so on, you will find frequent updates focused on helping patients with problems with drugs, of course if you need rehab you can also…
LinkedIn is one of the most popular social networks around — but can Pharma suppliers, consultants and recruiters really use it to find new clients? You bet you can, and here’s an infographic to prove it! Packed full of stats that show exactly which Pharma decision-makers are on LinkedIn, waiting for your connection request (did…
We were really thrilled to have such a great turnout and enthusiastic feedback from the webinar we ran this week with the PharmaMKT LinkedIn group, “The 7 Biggest Mistakes Pharma Companies Make on LinkedIn… and How You Can Avoid Them Too.” During the session we packed a lot in, covering everything from how to use…
Ok, ok, so it’s a bit of a trick question. No Pharma brand shines on Google+. In fact, it’s extremely difficult to find any Pharma companies with active Google+ accounts at all. The tiny number that are active have minute followings, a few hundred people at most. Why are they not there? It’s probably unrealistic…
Every day on Twitter, in webinars and in conferences, the Pharmaceutical industry discusses the challenges and opportunities for the sector in social media. The conversation, though, almost exclusively revolves around the needs of drug companies, their regulatory restrictions, relationships with doctors and patients and so on. What about businesses that sell to other Pharmaceutical companies…
If I told you that my company “uses its capability in proprietary logic-based machine learning and chemoinformatics (INDDEx™), based on the patented SV-ILP method (Patent number 8126823), to undertake drug discovery programmes for its clients,” would you have a clue what I was talking about – at least before reading that sentence three times? Quite…
Have Pharma marketers got it all wrong? Instead of trudging uneasily into the world of social media, should they be going back to the future – to email marketing? I’m asking because, according to reports, one of the presentations that generated most excitement at the Eye for Pharma conference in Barcelona this week concerned the…
